138 related articles for article (PubMed ID: 19286393)
1. Direct determination of the primary binding site of cisplatin on cytochrome C by mass spectrometry.
Zhao T; King FL
J Am Soc Mass Spectrom; 2009 Jun; 20(6):1141-7. PubMed ID: 19286393
[TBL] [Abstract][Full Text] [Related]
2. Probing the interaction of cisplatin with cytochrome C by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
Zhang N; Du Y; Cui M; Xing J; Liu Z; Liu S
Anal Chem; 2012 Jul; 84(14):6206-12. PubMed ID: 22746312
[TBL] [Abstract][Full Text] [Related]
3. A mass spectrometric comparison of the interactions of cisplatin and transplatin with myoglobin.
Zhao T; King FL
J Inorg Biochem; 2010 Feb; 104(2):186-92. PubMed ID: 19945168
[TBL] [Abstract][Full Text] [Related]
4. Determination of binding sites in carboplatin-bound cytochrome c using electrospray ionization mass spectrometry and tandem mass spectrometry.
Yang G; Miao R; Jin C; Mei Y; Tang H; Hong J; Guo Z; Zhu L
J Mass Spectrom; 2005 Aug; 40(8):1005-16. PubMed ID: 15934026
[TBL] [Abstract][Full Text] [Related]
5. Mass-spectrometric characterization of cisplatin binding sites on native and denatured ubiquitin.
Zhao T; King FL
J Biol Inorg Chem; 2011 Apr; 16(4):633-9. PubMed ID: 21365334
[TBL] [Abstract][Full Text] [Related]
6. Activation of Platinum(IV) Prodrugs by Cytochrome c and Characterization of the Protein Binding Sites.
Lasorsa A; Stuchlíková O; Brabec V; Natile G; Arnesano F
Mol Pharm; 2016 Sep; 13(9):3216-23. PubMed ID: 27505350
[TBL] [Abstract][Full Text] [Related]
7. Top-down characterization of proteins and drug-protein complexes using nanoelectrospray tandem mass spectrometry.
Mandal R; Li XF
Rapid Commun Mass Spectrom; 2006; 20(1):48-52. PubMed ID: 16308874
[TBL] [Abstract][Full Text] [Related]
8. High resolution mass spectrometry for studying the interactions of cisplatin with oligonucleotides.
Egger AE; Hartinger CG; Ben Hamidane H; Tsybin YO; Keppler BK; Dyson PJ
Inorg Chem; 2008 Nov; 47(22):10626-33. PubMed ID: 18947179
[TBL] [Abstract][Full Text] [Related]
9. The X-ray structure of the primary adducts formed in the reaction between cisplatin and cytochrome c.
Ferraro G; Messori L; Merlino A
Chem Commun (Camb); 2015 Feb; 51(13):2559-61. PubMed ID: 25567806
[TBL] [Abstract][Full Text] [Related]
10. Shape changes induced by N-terminal platination of ubiquitin by cisplatin.
Williams JP; Phillips HI; Campuzano I; Sadler PJ
J Am Soc Mass Spectrom; 2010 Jul; 21(7):1097-106. PubMed ID: 20227292
[TBL] [Abstract][Full Text] [Related]
11. Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles.
Peleg-Shulman T; Najajreh Y; Gibson D
J Inorg Biochem; 2002 Jul; 91(1):306-11. PubMed ID: 12121789
[TBL] [Abstract][Full Text] [Related]
12. TCEP-based rSDS-PAGE AND nLC-ESI-LTQ-MS/MS for oxaliplatin metalloproteomic analysis.
Mena ML; Moreno-Gordaliza E; Gómez-Gómez MM
Talanta; 2013 Nov; 116():581-92. PubMed ID: 24148449
[TBL] [Abstract][Full Text] [Related]
13. Differences in binding kinetics, bond strength and adduct formation between Pt-based drugs and S- or N-donor groups: A comparative study using mass spectrometry techniques.
Artiaga G; Iglesias-Jiménez A; Moreno-Gordaliza E; Mena ML; Gómez-Gómez MM
Eur J Pharm Sci; 2019 Apr; 132():96-105. PubMed ID: 30844436
[TBL] [Abstract][Full Text] [Related]
14. Novel biomarkers of protein oxidation sites and degrees using horse cytochrome c as the target by mass spectrometry.
Zong W; Liu R; Guo C; Sun F
Spectrochim Acta A Mol Biomol Spectrosc; 2011 May; 78(5):1581-6. PubMed ID: 21377407
[TBL] [Abstract][Full Text] [Related]
15. The influence of methionine-containing peptides on the reaction of carboplatin with 5'-guanosine monophosphate: a comparison with cisplatin.
Kleine M; Wolters D; Sheldrick WS
J Inorg Biochem; 2003 Dec; 97(4):354-63. PubMed ID: 14568240
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive identification of the binding sites of cisplatin in hen egg white lysozyme.
Zhang N; Du Y; Cui M; Liu Z; Liu S
Anal Bioanal Chem; 2014 Jun; 406(15):3537-49. PubMed ID: 24748452
[TBL] [Abstract][Full Text] [Related]
17. Identification of binding sites of cisplatin to human copper chaperone protein Cox17 by high-resolution FT-ICR-MS.
Li L; Guo W; Wu K; Zhao Y; Luo Q; Zhang Q; Liu J; Xiong S; Wang F
Rapid Commun Mass Spectrom; 2016 Aug; 30 Suppl 1():168-72. PubMed ID: 27539433
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of cisplatin binding sites in human serum proteins using hyphenated multidimensional liquid chromatography and ESI tandem mass spectrometry.
Will J; Wolters DA; Sheldrick WS
ChemMedChem; 2008 Nov; 3(11):1696-707. PubMed ID: 18855968
[TBL] [Abstract][Full Text] [Related]
19. Clarification of a peak at m/z 1634 from tryptically digested cytochrome c.
Shin S; Yang HJ; Kim JH; Kim J; Lee JH; Park KH; Kim HS; Kim J
J Mass Spectrom; 2012 Dec; 47(12):1576-81. PubMed ID: 23280746
[TBL] [Abstract][Full Text] [Related]
20. Direct determination of the binding sites of cisplatin on insulin-like growth factor-1 by top-down mass spectrometry.
Zhang N; Liu H; Cui M; Du Y; Liu Z; Liu S
J Biol Inorg Chem; 2015 Jan; 20(1):1-10. PubMed ID: 25344342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
